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Abstract
Background: Mutations in the FKBP10 gene were first described in patients with Osteogenesis imperfecta type III.
Two follow up reports found FKBP10 mutations to be associated with Bruck syndrome type 1, a rare disorder
characterized by congenital contractures and bone fragility. This raised the question if the patients in the first
report indeed had isolated Osteogenesis imperfecta or if Bruck syndrome would have been the better diagnosis.
Methods: The patients described here are affected by severe autosomal recessive Osteogenesis imperfecta without
contractures.
Results: Homozygosity mapping identified FKBP10 as a candidate gene, and sequencing revealed a base pair
exchange that causes a C-terminal premature stop codon in this gene.
Conclusions: Our study demonstrates that FKBP10 mutations not only cause Bruck syndrome or Osteogenesis
imperfecta type III but can result in a severe type of isolated Osteogenesis imperfecta type IV with prenatal onset.
Furthermore, it adds dentinogenesis imperfecta to the spectrum of clinical symptoms associated with FKBP10
mutations.
Background
Osteogenesis imperfecta (OI) is a rare monogenic disor-
der that shows both clinical and genetic heterogeneity.
The disorder is characterized by bone fragility that var-
ies in severity between the different OI subtypes. In the
majority of patients the disorder is caused by dominant
mutations in the procollagen genes COL1A1 and
COL1A2 [1-4]. Even rarer than the dominant disorders
are the autosomal recessive forms of OI for which sev-
eral genes are known by now. These genes are mainly
involved in the processing, assembly and trafficking of
procollagen chains, a multi-step process that involves a
large number of critical post-translational modifications.
Homozygosity for mutations in CRTAP, LEPRE1, PPIB,
or OSTERIX has been shown to cause mostly severe
t y p e so fO It h a tr e s u l tf r o mo v e r m o d i f i c a t i o no fp r o c o l -
lagen chains and their retention in the rER [2-7]. Auto-
somal recessive brittle bone disease without procollagen
overmodification can be caused by mutations in either
SERPINH1 or FKBP10 genes that encode the collagen
chaperone-like proteins HSP47 and FKBP65, respectively
[1,3]. Basic pathomechanisms of OI initiated by muta-
tions in these genes might include a failure to mature
type I procollagen trimers and increased protease sensi-
tivity [3,8]. The pathomechanisms of another OI gene,
SERPINF1, are still unknown [9]. Mutations in FKBP10
were first described in patients with a moderate to mod-
erate/severe form of OI type IV (OMIM 610968) [1].
Two follow up reports presented patients in which
FKBP10 mutations were associated with Bruck syn-
drome type 1, a rare disorder characterized by congeni-
tal contractures and bone fragility [10-12]. The question
was raised if the patients in the first report indeed had
isolated OI or if Bruck syndrome would have been the
better diagnosis [11,12]. We here describe three patients
showing that FKBP10 mutations not only can cause iso-
lated OI but that the spectrum of clinical symptoms is
much broader than previously described.
Methods
Patients
The three affected brothers, their sister and their par-
ents provided informed consent for molecular testing,
clinical assessment and the publication of their
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healthy German medical students were used as controls.
The experiments were performed in accordance to the
Helsinki Declaration and approved by the Ethics com-
mittee of the University of Munich.
Homozygosity mapping and FKBP10 sequencing
Genomic DNA samples of family members I1-2, II1-2,
and II4-5 were genotyped using the Affymetrix Axiom™
Genome-Wide Human Array, featuring 567,096 SNP
markers (Affymetrix, Santa Clara, CA, USA). Extended
runs of homozygosity (ROHs) shared by the three
affected brothers were assessed in comparison to the
unaffected family members using the program Homozy-
gosityMapper (http://www.homozygositymapper.org)
[13]. Prioritization of candidate genes within the homo-
zygous region was performed by the program GeneDis-
tiller (http://www.genedistiller.org) [14] and by
comparison to PubMed entries (http://www.ncbi.nlm.
nih.gov/pubmed). The complete coding sequence of the
FKBP10 gene was amplified and directly sequenced.
Results
Clinical findings
The three affected brothers, aged 46 (II1), 44 (II4), and
43 (II5) years, were born to healthy, unrelated parents.
There is no family history of bone diseases or major
malformations. The oldest brother was born without
fractures but showed delayed motor development during
his first year of life. He had his first fracture at age 9
months. The second brother was born with multiple
fractures. Multiple fractures of the upper extremities at
birth were also suspected in the youngest brother but
not confirmed by X-ray. So far each of the brothers
already had 70-100 fractures and breaks still occur.
Severe progressive kyphoscoliosis has caused reduced
lung capacity in all three brothers, and they are wheel-
chair bound due to long bone deformities. None of the
brothers showed contractures or webbing at birth. The
brothers are of short stature (120-140 cm, <3 %tile) with
remarkable hypermobile joints (Figure 1). Relevant lab
results such as alkaline phosphatase (73 U/l) are within
the normal range. The primary teeth were discoloured
and rapidly wore down, thus showing typical signs of
dentinogenesis imperfecta (Figure 2). The permanent
teeth are less affected. Blue sclera were noted in child-
hood but are no longer present.
Genetic studies
Homozygosity mapping detected two candidate ROHs
in the chromosomal regions 11q25 and 17q21, respec-
tively (Figure 1B). The ROH on 17q21.2 (17:
39727018-44200191, rs1010594-rs9910284, NCBI Gen-
ome Build 37.3) harbors the FKBP10 gene encoding
the FKBP65 protein (Additional File 1, Figure S1).
Sequencing revealed a homozygous nucleotide
exchange in exon 7 that changes an arginine codon
into a stop codon (c.1207C>T, FKBP65-p.(Arg403*)
(Figure 1C).
I                1           2
A                                   B
C
Arg403X homozygous Arg403X/wild type
HSA17
II     1         2          3         4          5
III              1            2
Figure 1 Genetic Studies A, Pedigree of the OI family. Black
pedigree symbols, affected brothers, homozygous; symbols marked
by black dots, unaffected family members that are heterozygous for
the mutation; unmarked symbols, unaffected family members that
were not available for analysis. B, Genome wide plot of
Homozygosity Mapper. Red bars indicate regions with extended
ROH at chromosomal regions 11q25 and 17q21.2, shared by the
three affected brothers. Homozygosity Score threshold 0.8; HSA,
homo sapiens chromosome. C, Sequencing results. Parts of FKBP10
exon 7 are shown. Left side, OI patient II1 homozygous for Arg403X;
right side, healthy sister (II2) heterozygous for Arg403X.
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Figure 2 Clinical phenotype. A-B, extended left arm II1, II5. Upper
arm is severely shortened in II1 and instabilized by pseudarthrosis in
II5. Webbing and contractures are absent; C, joint hypermobility,
demonstrated by II4; D, Radiographs of left leg and E, left side of
thorax showing severe kyphoscoliosis (II4); F, Dentiogenesis
imperfecta (primary teeth) in II5.
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We identified a homozygous C-terminal premature stop
codon (FKBP65-p.Arg403X) in the FKBP10 gene causing
OI in three affected siblings of a family with autosomal
recessive inheritance. Both parents derived from two
neighbouring small villages in Bavaria, suggesting a
restricted genetic variability and a potential accumula-
tion of recessive founder mutations in this rather iso-
lated population. Although estimates of the relative
relationship by identity-by-state allele sharing did not
indicate consanguinity (see Additional File 1), homozyg-
osity mapping was successfully applied to identify a cau-
sative homozygous FKBP10 founder mutation. Our
study demonstrate that homozygosity mapping repre-
sents a suitable diagnostic approach to map recessive OI
genes even in outbred populations [15].
The first FKBP10 mutations were found in families that
were described as having OI but for which no contrac-
tures or webbing were reported [1]. Shaheen et al.
reviewed the figures in the original publication and ques-
tioned the absence of webbing [11,12]. Both contractures
and webbing were present in their own patients as well
as in all but two of the patients reported by Kelley et al.
[10] The patients were therefore diagnosed with Bruck
syndrome type 1, a distinct form of OI that is character-
ized by brittle bone disease and arthrogryposis multiplex
congenita. Interestingly, case 2 and 4 in the report from
Kelley et al. had OI but did not fulfil the criteria for
Bruck syndrome [10]. In our family none of the three
brothers had any contractures at birth or showed web-
bing. Thus, taken together, the previously reported
patients and the family described here demonstrate that
FKBP10 can cause either Bruck syndrome or isolated OI.
Additional families need to be collected to answer the
question if these two clinical phenotypes are associated
with specific mutations, or if isolated OI and Bruck syn-
drome can occur in the same family.
So far it is not known if the severity of the disorder is
correlated to the position of the mutation within the
FKBP10 gene. Most patients carry frame shifting muta-
tions that are located in the N-terminal half of the gene
and are likely to cause nonsense mediated decay (NMD)
(1). Interestingly, the affected brothers described here
are homozygous for a C-terminal premature stop codon
that, according to its vicinity to intron 7, might not
initiate NMD [16,17]. The resulting truncated protein
would still have the protein-binding PPIase domains
that are necessary for its chaperone function but would
miss the putative rER-retention sequence (HEEL). The
chaperone function might have destructive effects if
exhibited outside the rER.
With the exception of some of the patients described
by Alanay et al. [1] most previously published patients
with FKBP10 mutations had a moderate to moderate-
severe form of the disorder that is best classified as OI
type III. The data summarized in Table 1 show that
fractures mostly started a few weeks after birth, some-
times even later, but not pre- or perinatally [1,10-12].
Progressive skeletal deformities were rarely described. In
our family at least one, but more likely two of the
affected brothers were already born with multiple frac-
tures. Subsequently, all three brothers developed
extreme deformities of their long bone and spines, ful-
filling the criteria for severe OI (Figure 2). Furthermore,
dentinogenesis imperfecta was present in all three
brothers but has so far not been described as a feature
of patients with FKBP10 mutations [1,10-12]. The com-
bination of symptoms in our family does not match the
classification of OI type III but rather suggests that this
family belongs to the subgroup of patients with OI type
Table 1 Summary of known FKBP10 mutations
Mutations in OI and Brucks syndrome patients Type Position OI severity Reference
c.117_152del (p.Leu41GlnfsX22) homozygous frame shift deletion upstream of 1st
PPIase domain
Fractures beginning at age 3
years
[13]
c.321_353del (p.Gly107-Leu117del) homozygous in frame deletion 1st PPIase domain Fractures beginning in
infancy
[11]
c.321_353del (p.Met107-Leu117del*)/c.1276-
_1277insC (p.Glu426ProfsX479) heterozygous
in frame deletion/frame
shift insertion
1st PPIase domain/
HEEL domain
nm [13]
c.344G>A, (p.Arg115Gln)/c.831dupC (p.
Gly278ArgfsX295) heterozygous
frame shift insertion/
missense mutation
1st PPIase domain/ Fractures beginning in
infancy (fist weeks of life)
[13]
c.831dupC* (p.Gly278ArgfsX295) homozygous frame shift duplication between 2nd and 3rd
PPIase domain
Fractures beginning in
infancy (2 months of age)
[11]
[13]
c.1016_1023dup (p.Thr342GlyfsX26) frame shift duplication 3
rd PPIase domain Fractures beginning in
infancy (7 months of age)
[14]
c.1207C>T (R403X) homozygous nonsense mutation HEEL domain Multiple fractures in fetal
period
Family
presented
here
Predicted amino acid mutations are given in brackets; *mutation nomenclature has been adapted to match the entries in the Osteogenesis Imperfecta Variant
Database (https://oi.gene.le.ac.uk);
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nogenesis imperfecta.
Conclusions
Taken together, our study shows that a severe, progres-
sive course of OI type IV with pre- or perinatal onset of
fractures and dentinogenesis imperfecta has to be added
to the spectrum of clinical features that can be asso-
ciated with FKBP10 mutations. We also demonstrate
that homozygosity mapping represents a suitable diag-
nostic approach to map recessive OI genes even in
outbred populations.
Additional material
Additional file 1: Supplementary Figure S1: Runs of homozygosity
at 17q21.2. Supplementary Figure S2: Graphical relative relationship of
individuals with different degrees of relationship.
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